Phage therapy is recognized as a promising alternative to antibiotics in treating pulmonary bacterial infections, however, its use has not been reported for treating secondary bacterial infections dur

NIAID Data Ecosystem50

COVID-19: Přehled reinfekcí

COVID-19再感染

PCR检测数据与分析

Datová sada obsahující denní přehled suspektních případů reinfekcí COVID-19, které jsou v souladu s doporučením ECDC určeny na základě nově pozitivního PCR testu s minimálním odstupem 60 dnů od předch

Czech Data Portal30

Incidence, severity, risk factors and outcomes of SARS-CoV-2 reinfections during the Omicron period: a systematic review and meta-analysis

COVID-19再感染

流行病学

Our previous systematic review estimated the cumulative incidence of SARS-CoV-2 reinfections as 1.16% (1.01%-1.33%) during the pre-Omicron period. The Omicron variant that emerged in November 2021 was

DataCite Commons2025-07-01 更新50

Nasopharyngeal microbiota and COVID-19

咽部微生物组

COVID-19再感染

Super-dominant pathobiontic bacteria in the nasopharyngeal microbiota cause secondary bacterial infection in COVID-19 patients and aggravate pneumonia.

NIAID Data Ecosystem40

Systematic study of COVID early reinfections and persistence. undefined

资源简介：

相关数据集